Síntese de Omeprazol para Inibidores da Bomba de Prótons

Controle do ácido gástrico com química de seleção quiral

Pharmaceutical & Drug Manufacturing Global Industrial Scale $3.5 billion

Visão geral

Omeprazole is the first proton pump inhibitor (PPI) to reach the market and remains one of the most prescribed medications globally for treating gastric acid disorders, peptic ulcers, and GERD. The synthesis involves a multi-step process building the benzimidazole-pyridine core structure. The chiral version, esomeprazole (the S-enantiomer), represents a significant pharmaceutical advancement, produced using an asymmetric oxidation that won AstraZeneca substantial patent protection.

Processo químico

2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.

Thioether intermediate + m-CPBA → Omeprazole (sulfoxide)
For esomeprazole: Ti(OiPr)₄/(R,R)-DET/cumene hydroperoxide → S-omeprazole (>99.5% ee)

Matérias-primas

  • 5-Methoxy-2-mercaptobenzimidazole — Multi-step synthesis from o-phenylenediamine (Core structure)
  • 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine — Pyridine chemistry (Pyridine moiety)
  • m-CPBA (meta-chloroperoxybenzoic acid) — Chemical synthesis (Oxidizing agent)

Produtos finais

  • Omeprazole (C₁₇H₁₉N₃O₃S) — Proton pump inhibitor for GERD and ulcers (Racemic or enantiopure form)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.

Considerações de segurança

Inovações recentes

Biocatalytic oxidation using engineered cytochrome P450 enzymes and Baeyer-Villiger monooxygenases offers enantioselective sulfoxidation under mild conditions, potentially replacing chemical oxidants entirely.

Escala de produção

800

toneladas/ano

$3.5 billion

valor de mercado

Mais em Pharmaceutical & Drug Manufacturing

Produção de Insulina Humana Recombinante

Global Industrial Scale

Produção de Penicilina G por Fermentação

Global Industrial Scale

Produção Semi-Sintética de Amoxicilina

Global Industrial Scale

Síntese de Aspirina por Acetilação do Ácido Salicílico

Global Industrial Scale

Síntese de Cloridrato de Metformina

Global Industrial Scale

Síntese de Ibuprofeno — Processo Verde BHC

Global Industrial Scale

Síntese de Paracetamol (Acetaminofeno)

Global Industrial Scale

Frequently Asked Questions

What industry uses Síntese de Omeprazol para Inibidores da Bomba de Prótons?
Síntese de Omeprazol para Inibidores da Bomba de Prótons is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Síntese de Omeprazol para Inibidores da Bomba de Prótons?
2-Chloromethyl-3,5-dimethyl-4-methoxypyridine is coupled with 5-methoxy-2-mercaptobenzimidazole to form the thioether intermediate. Selective oxidation with m-CPBA or titanium-mediated asymmetric oxidation yields the sulfoxide drug substance.
What is the economic significance of Síntese de Omeprazol para Inibidores da Bomba de Prótons?
Síntese de Omeprazol para Inibidores da Bomba de Prótons has a market value of $3.5 billion and annual production of 800 tons.
What is the environmental impact of Síntese de Omeprazol para Inibidores da Bomba de Prótons?
Multi-step synthesis generates significant organic waste including halogenated solvents. m-CPBA oxidation produces m-chlorobenzoic acid waste. Modern production increasingly uses catalytic oxidation methods and solvent recycling to minimize environmental impact.
What raw materials are used in Síntese de Omeprazol para Inibidores da Bomba de Prótons?
The main raw materials include: 5-Methoxy-2-mercaptobenzimidazole, 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine, m-CPBA (meta-chloroperoxybenzoic acid).